Farther Finance Advisors, LLC

Position in BIO — Bio-Rad Laboratories, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in BIO

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$223,437

+$184,691 QoQ

Shares Held

761

+447.5% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#262

of 397 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $24,008,567 across 89 Medical Devices names. BIO ranks #11 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	73,946	$6,709,860
2	SYK	Stryker Corp	17,426	$5,486,401
3	MDT	Medtronic plc	65,993	$5,162,632
4	BSX	Boston Scientific Corp	28,699	$1,224,873
5	EW	Edwards Lifesciences Corp	12,482	$1,129,121
6	DXCM	Dexcom Inc	9,967	$671,277
7	STE	STERIS plc	2,980	$627,498
8	GEHC	GE HealthCare Technologies Inc.	8,545	$546,965

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$223,437	761	+447.5%	Shares	Sole	2026-07-17
2026-03-31	$38,746	139	-24.5%	Shares	Sole	2026-04-07
2025-12-31	$55,750	184	+76.9%	Shares	Sole	2026-01-23
2025-09-30	$29,160	104	+52.9%	Shares	Sole	2025-10-14
2025-06-30	$16,409	68	+17.2%	Shares	Sole	2025-07-11
2025-03-31	$14,126	58	-50.0%	Shares	Sole	2025-04-14
2024-12-31	$38,107	116	-8.7%	Shares	Sole	2025-02-10
2024-09-30	$42,491	127	+25.7%	Shares	Sole	2024-10-29
2024-06-30	$27,584	101	-33.6%	Shares	Sole	2024-07-31
2024-03-31	$52,572	152	+36.9%	Shares	Sole	2024-05-14
2023-12-31	$35,840	111	+40.5%	Shares	Sole	2024-02-15
2023-09-30	$28,317	79	+36.2%	Shares	Sole	2023-11-14
2022-12-31	$24,388	58	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.